In addition to the services we offer as a CDMO to companies in the pharmaceutical and related sectors, our research group leads four cutting-edge research lines focused on the pharmaceutical development of new drugs:
Development of Innovative Pharmaceutical Forms and Application of the SeDeM Diagram
PI: PhD. Josep Maria Suñé Negre
Development of Pediatric Medicines:
PI: PhD. Pilar Pérez Lozano and PhD. Encarna García Montoya
Development of 3D-Printed Medicines:
PI: PhD. Montserrat Miñarro Carmona and PhD. Encarna García Montoya
Development of Functionalized Nanoparticles for DNA and RNA Therapies:
PI: PhD. Marc Suñé Pou
